New Cara Mobile App Improves Health Decisions

VANCOUVER, British Columbia, May 20, 2021 (GLOBE NEWSWIRE) — Treatment.com International Inc. “Treatment or The Company” (CSE: TRUE) is a healthcare technology company that has developed an AI platform to help make better health decisions. Treatment is launching their first product, Cara.Health that will leverage the proprietary AI to provide health insights and health management in a supportive digital tool.

1 billion consumers turn to Google everyday to look up a health question. The results are not personalized or considerate of their health history, and can lead to confusion and fear. Cara’s AI takes into account each individual’s health profile and their symptoms to provide a more accurate and personalized recommendation about what they might have.

“With Cara, the consumer can simply type in a symptom that’s bothering them, and get a very accurate and unique assessment for the condition they might have, as well as information about treatment and prevention,” says John Fraser, CEO of Treatment.com, the founders of Cara.Health. “We know this will help millions of people, especially those who have regular health concerns or who are looking after their family and having to make healthcare decisions every day.”

Cara’s AI technology will provide intelligent follow up to the consumer to ensure they are getting the healthcare support and management they need. The AI engine builds a unique health profile around each individual by pulling in a multitude of data inputs, including wearable smart technology and other digital healthcare monitoring and tracking apps.

The Cara mobile app is powered by a next-generation AI software engine that was developed by a global team of doctors over the last 5 years. Paired with the ability to track, monitor and follow up with every user, and their family members, the Cara app is designed to truly help put healthcare power in the patient’s hands.

The Cara app is launching for free this summer in Canada and US. CEO John Fraser comments, “with better information, consumers can make better decisions, and their overall health will be better managed.”

About Treatment.com

Treatment.com is a disruptive healthcare technology company that is harnessing the power of AI to help Canadians improve their health through personalized recommendations and insights. Based in Vancouver, the company spent the last five years working with a team of world-class doctors, engineers, mathematicians, and AI specialists to develop a complex AI engine that leverages the most robust, personalized data to generate highly predictive and accurate insights. Treatment.com is the parent company of Cara. This summer, Cara will be empowering Canadians to take control of their health with the launch of an innovative mobile app powered by this exclusive AI engine.

For more investor information on Treatment.com please visit https://treatment.com/investors/.

Forward Looking Statement

This news release contains forward-looking statements relating to the future operations of Treatment.com, International, Inc. (Treatment) and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of Treatment, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment’s expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Treatment. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Treatment will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.

For more information:

Investor Contact: investors@treatment.com